Pfizer May Buy Angiosyn, Signs Deal with Rigel
636655
Pfizer Inc. said on Thursday it is in  talks to acquire a private biotechnology company called  Angiosyn Inc., which is developing a drug for macular  degeneration, the leading cause of blindness in the elderly.
445972
Pfizer Inc. has agreed to license a  set of potential drugs for the prevention of stroke and heart  attacks from Germany's Schering, the two companies said on  Wednesday.
165412
Enablex, also known as darifenacin, was approved by the Food and Drug Administration. Novartis (nyse: NVS - news - people ) had purchased the drug from Pfizer (nyse: PFE - news - people ) for $225 million
561496
The Swiss drug maker said it would start a tender offer to acquire Ventana Medical Systems for about $3 billion.
12052
Drug maker Pfizer Inc. PFE.N on  Tuesday said it won regulatory clearance to sell its  anti-fungus medicine Vfend to treat serious hospital-acquired  bloodstream infections.
683778
Pfizer Inc. , the world's largest drug company, is using the results of a study it sponsored to persuade doctors to switch patients to pricier doses of its blockbuster drug, Lipitor . And according to the latest sales figures, the marketing pitch is working.
327285
Drug and nutritional products maker Perrigo Co. is buying pharmaceutical company Agis Industries Ltd. for about $818 million as part of its effort to expand into the generic prescription drug market.
277073
The company said that it also would consider âselectâ acquisitions and was looking for other pharmacy-related health care opportunities.
457534
Pfizer Inc. may strengthen the warning label for its painkiller Bextra to account for more information about a rare but serious skin reaction.
668273
Pfizer Inc. said on Thursday it is in talks to acquire a private biotechnology company called Angiosyn Inc., which is developing a drug for macular degeneration, the leading cause of blindness in the elderly.
85851
Pfizer Inc , the world's largest drug maker, said on Friday it is in talks with investors about spinning off its Japanese research and development laboratory, albeit as a much smaller organization.
581751
THE REGION Idera Pharmaceuticals Inc. of Cambridge signed a drug-development deal with Merck &amp; Co. in which the New Jersey drug giant will pay $20 million cash and buy $10 million in stock for the rights to use Idera's immune-boosting technology in potential Merck vaccines. If the vaccines succeed, the deal could be worth up to $425 million in additional ...
80575
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry the strictest possible warning alerting doctors  of the risk of a potentially deadly skin reaction, the company  said in a regulatory filing.
355446
Pfizer said today that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to assess the cardiovascular benefits of the drug.
593570
Pfizer Inc. said Friday the U.S. Food and Drug Administration has approved its medication for pain caused by nerve damage from diabetes or shingles.
69906
Many patients on the cholesterol drug are switching to a cheaper alternative, but Pfizer is not letting its flagship product go down without a fight.
590148
Schering-Plough Corp. SGP.N is   seriously considering approaching Bristol-Myers Squibb Co.   BMY.N about a possible merger, according to a report in The   Star-Ledger newspaper on Friday.